News

Sarepta Therapeutics SRPT announced that the FDA has granted platform-technology designation to its viral vector rAAVrh74, ...
The Platform Technology Designation, which predates the current FDA leadership, is designed to streamline the drug ...
A Sarepta police officer has been arrested in connection with an incident where a dog was shot and killed last month.
The FDA has designated the viral vector rAAVrh74, which Sarepta Therapeutics, Inc. (NASDAQ:SRPT) uses in its gene therapy ...
A Sarepta police officer has been arrested in connection with an incident where a dog was shot and killed last month.
The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...
The Webster Parish Sheriff's Office is investigating two officers in two different towns accused of shooting dogs.
Sarepta Therapeutics’ gene therapy to treat limb girdle muscular dystrophy type 2E/R4 gets US FDA platform technology designation: Cambridge, Massachusetts Friday, June 6, 2025, ...
RegenXBio has shared updated phase 1/2 data on its Duchenne muscular dystrophy (DMD) gene therapy, providing evidence that ...
Interim results from a small group of children in a Phase I/II trial are essentially in line with that of Elevidys, according ...
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
A Sarepta, LA police officer has been arrested in connection with an incident where a dog was shot and killed last month.